Viswanathan Ramakrishnan to Leukemia
This is a "connection" page, showing publications Viswanathan Ramakrishnan has written about Leukemia.
Connection Strength
0.103
-
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2. Clin Cancer Res. 2013 Apr 01; 19(7):1873-83.
Score: 0.103